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Introduction
Urban air pollutants are a complex mixture
ofmany organic and inorganic compounds.
Most ofthe research on the potential health
effects of air pollutants has been associated
with the major pollutants ozone, carbon
monoxide, nitrogen oxide (NOX) and air
toxics. The term air toxics was coined in
the early 1980s by the U.S. Environmental
Protection Agency (U.S.EPA) as a generic
name for air pollutants that could cause
adverse effects on human health. The
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attention was to focus on health effects as
opposed to so-called secondary effects such
as visibility degradation, property damage,
and crop and plant damage. The primary
focus on air toxics has been cancer as a
health end point. Other health effects of
possible concern are asthma and respiratory
toxicity (1), developmental and reproduc-
tive toxicity, central nervous system effects,
systemic effects such as liver and kidney
toxicity, cardiovascular toxicity and
immunotoxicity.
TheAmerican Cancer Societyhas estimat-
ed that there were approximately 980,000
cancer cases in the United States during
1989 (2). The 5-year survival rate averaged
51.4% for all cancers and 15.0% for lung
cancer during the past two decades.
Exposure to environmental pollutants has
been estimated to account for about 2% of
the total cancer cases (Figure 1). Nearlytwo-
thirds of the total cancer cases may be
caused by cigarette smoking and factors
related to diet.
Since the last two workshops on air toxi-
cs (3,4), a substantial research effort has be
directed toward developing reliable data
that can been used to form the basis for
quantifying the cancer risks associated with
exposure to ambient air pollutants. These
studies have focused on complex mixtures
associated with combustion processes (e.g.,
particle emissions from mobile sources and
wood burning) and specific compounds
such as benzene, 1,3-butadiene, acetalde-
hyde, formaldehyde, methanol, polycyclic
aromatic hydrocarbons (PAH), and PAH
derivatives (e.g., nitrated PAH).
Today, it is recognized that reliable quan-
titative risk assessments must incorporate a
stepwise systems approach that integrates
the qualitative and quantitative character of
emissions from mobile and stationary
sources, atmospheric transport and chem-
istry, the assessment of exposure levels,
dose-response relationships, and health end
points. Such a risk characterization strategy
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Figure 1. Causes of U.S. cancer incidence,(%).
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has been formalized by the U.S. National
Research Council (5,6) (Figure 2).
Current risk assessment models have
indicated that there is a relatively low cancer
risk associated with exposure to ambient air
pollutants in the United States where strin-
gent emission control regulations have
been implemented. The current models
estimate an upper limit of between 1700
and 2700 excess cancer cases per year from
exposure to ambient air toxic pollutants in
the United States (7).
Although great progress has been made,
there are large degrees of uncertainty asso-
ciated with estimates of excess cancer inci-
dence. There are still significant gaps in
knowledge concerning the concentration
and distribution of toxics in ambient air,
the chemical and physical processes that
affect their concentration, the distribution
and fate ofthese species in the atmosphere,
the quantitative exposure to humans, and
the potential human health and environ-
mental impacts of exposure to these chemi-
cal species.
A major change in the approach to
undertaking research on air pollutants has
been an increasing focus on international
collaborative efforts (collaboration between
industry, government, and university orga-
nizations) and on the creation oforganiza-
tions to help foster these collaborations
such as the U.S. Health Effects Institute
(8), the Swedish Urban Air Project, the
Danish Air Project (9), the U.S. Auto/Oil
Air Quality Improvement Research Program
(10) and several other coordinating groups.
This report summarizes significant
research findings since the last two meet-
ings and provides future research recom-
mendations from the meeting conference
and previous risk assessment workshop
with respect to assessing the potential
human health risk associated with exposure
to outdoor ambient air toxics. Although
the workshop dealt primarily with air toxics
in outdoor ambient air, it was recognized
that exposure to indoor air pollutants can
be a much more important source of expo-
sure because most people spend 20% or
less oftheir time outdoors (11,12). A spe-
cial emphasis was placed on international
approaches to meeting the recommenda-
tions presented in this paper.
The workshop participants emphasized
that other health effects may be as impor-
tant or even more important than cancer.
The spectrum of these other potential
adverse health effects include asthma,
chronic obstructive pulmonary disease
(COPD), cardiovascular diseases, and heri-
table genetic effects. Other less quantitative
effects include an increased incidence of
colds, allergies, and other respiratory ail-
ments. All of these effects are of potential
public health concern because they might
affect large numbers ofpeople.
In order to reduce the multitude of per-
tinent references that could be cited in each
section of this report, several of the papers
published in this volume were written to
serve as critical reviews of current research
efforts and results. Key references from
other recent workshop proceedings, feature
articles, and reviews were used to provide
additional background material for this
research assessment.
Emission Sources and
Characterization
Urban air is affected by many different
local emission sources as well as by long-
range transport from other urban or indus-
trial areas. The sources considered in this
workshop included those from anthro-
pogenic sources (e.g., motor vehicles,
domestic heating and cooking, power gen-
eration, and manufacturing processes) and
natural or biogenic processes (e.g., hydro-
carbon emissions from plants). The rela-
tive importance ofthese sources will depend
on their nature and magnitude, local geog-
raphy, and meteorological conditions.
Emission Inventories
Most air pollution studies have focused on
the measurement of the pollutants: ozone,
NOX, sulfur oxide (SOX), carbon monox-
ide (CO), total hydrocarbons (THC), and
respirable particles. Although there has
been a considerable effort to develop reli-
able emission inventories ofthese pollutants
or their precursors, significant errors still
exist. There are several reasons for such
discrepancies.
Because internal combustion engines,
power generation, and manufacturing tech-
nologies are being modified on a regular
basis to reduce emissions, improve produc-
tivity and quality, and reduce costs, the
qualitative and quantitative nature ofemis-
sions from these sources has been changing
with time. For example, hydrocarbon
(HC), CO, and NOX emissions from gaso-
line-fueled vehicles have been reduced by
more than 95% during the past 20 years in
the United States (13). Another problem
is that, in some cases, laboratory measure-
ments did not adequately predict emissions
from sources operating under real-world
situations. For example, careful measure-
ments on roadways and in vehicle tunnels
show that hydrocarbon emissions are two
to three times higher for in-service vehicles
than would be expected from laboratory
certification procedures (14,15). A primary
source of these discrepancies is probably
connected with malfunctioning and high-
mileage vehicles with inadequate emission
control devices. It has been estimated that
20% of these in-use vehicles produce 80%
of the total vehicle emissions inventory.
This is even more of a problem in some
parts of the world where high-mileage,
malfunctioning vehicles are much more
common. There also is a possible problem
with lead-contaminated-lead-free gasoline
in regions where both fuels exist simultane-
ously. Such contamination will reduce the
functionality of the catalyst, resulting in
increased emissions. Other environmental
factors, such as low-ambient temperatures
and high altitudes, can increase hydrocar-
bon and CO emissions from vehicles (13).
An increased effort has been undertaken
to determine the importance of nontradi-
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tional sources of emissions (e.g., cooking,
lawn mowers, boats, stationary diesels, etc.)
relative to vehicle and manufacturing emis-
sions. For instance, the EPA estimates that
a lawn mower operated for 1 hr releases as
many hydrocarbons as a car driven 60
miles, and an outboard motor (1 hr opera-
tion) releases as much hydrocarbons as a
car driven for 2500 miles.
UrbanAmbientAir
Three types ofurban air sheds generally are
recognized. The first is represented by
typical western cities such as Stockholm,
New York, and Tokyo. Mobile source
emissions are a significant source ofair pol-
lution in these cities. A second type of
urban air is represented by so-called
megacities such as Mexico City and Cairo
(16). For these cities, industrial sources,
residential cooking, refuse burning, and
road dust, in combination with exhaust
from old and poorly maintained vehicles,
contribute to most of the air pollution.
Finally, a third type of urban air pollution
is represented by city areas such as Beijing
and several urban areas in Eastern Europe
(17) where pollution primarily is caused by
coal combustion and industrial sources. In
all three types of urban air sheds, local cli-
matic conditions play an important role.
Thus, the complex interactions between
the emission sources and the climatic con-
ditions must be considered in anyanalysis.
Assessment of environmental trends on
local to global scales is among the greatest
challenges facing the scientific community
today. Fixed-site sampling, remote sam-
pling, and modeling form a triad of tech-
nologies that may be used for decision
making at the local to global level. Trends
in regional air quality are important when
establishing priorities for health effects
research because this research should account
forfuture airqualityand exposure data.
IndoorAirPollution
A major change in the approach to health
effects studies has been an increased
emphasis on indoor air pollution. Because
people spend a major portion oftheir time
indoors, indoor air quality is a major factor
in the total integrated exposure assessment.
It is known that indoor levels of nitrogen
dioxide (NO2) and CO are higher than
those in outdoor ambient airwhen unvented
gas cooking or coal orkerosene space heating
are used (18), while ozone exposures occur
primarily in the outdoor environment and
are low inside homes.
Several major studies have been under-
taken during the past few years to under-
stand the effect of environmental tobacco
smoke (ETS) on indoor air quality. A
recent EPA report (19) estimates that
secondhand smoke causes 3000 lung cancer
deaths a year among nonsmokers. The
study proposes that passive smoke be classi-
fied as a human carcinogen. This classifica-
tion was based upon studies that showed
increased lung cancer in nonsmoking spous-
es of smokers and respiratory problems in
children of smoking parents. In addition,
theAmerican HeartAssociation (1992) con-
cluded that between 35,000 and 40,000
heart disease deaths a year are linked to sec-
ondhand smoke.
Other sources of contamination include
subsurface transport of volatile contami-
nants into buildings near hazardous waste
sites (20), building and interior finish
materials, furnishings, cleaning products,
paint, and many other materials that con-
tain volatile organic compounds (21).
Vehide OccupantExposures
The amount oftime people spend in their
vehicles has increased steadily during the
past decade. Because of the continuous
inflow ofambient air, the level ofpersonal
exposure to vehide emissions during driving
is primarily determined by the emissions of
other vehicles on the road and is signifi-
cantly increased in highway tunnels (14),
in street canyons, and in traffic with signif-
icant numbers of vehicles with inadequate
emission controls. In addition, other
sources of exposure to vehicle occupants
include road dust and other pollutants
commonly present in urban ambient air
environments (e.g., ozone). This form of
exposure needs to be considered as a poten-
tially significant source for some people,
such as taxi, bus, and deliveryvehicle drivers,
who spend most of their working day in
their vehicles.
Characerizaion ofAirPollutants
The ability ofanalytical environmental sci-
entists to identify and quantify chemical
species in emissions and ambient air sam-
ples has advanced tremendously during the
past decade. It is now known that there are
thousands of individual chemical species
present in urban ambient air derived from
primary emission sources and atmospheric
chemical reaction products. The primary
focus areas for air-pollutant characteriza-
tion studies during the past several years
has included the speciation of gas-phase
hydrocarbon emissions from combustion
sources as needed to determine the ozone-
forming potential of these emissions, and
the identification of key chemical species
Table 1. Atmospheric phases of organic air pollutants.
Molecularweight range
Airpollutant phase of carbon(C)
Volatile organic Cl-Cll
compounds(VOCs)
Semi-volatile organic Clo-C17
compounds (SVOCs)
Particulate organic C5-C60+
material (POM)
that may be primarily responsible for
adverse human health effects.
The primary purpose of this workshop
was to review the potential health risks
associatedwith exposure to specific air toxics.
In this regard, it was agreed that the organic
species can be best described as existing in
the volatile (VOC), semivolatile (SVOC)
and polycyclic organic material (POM)
phases as listed in Table 1.
Since the early 1980s, chemical fraction-
ation and chemical analysis techniques
have been combined with bioassays to sim-
plify the process of identifying the key
mutagenic compounds present in air pollu-
tion samples (22). The Ames Salmonella
mutagenicity assay and a more sensitive
version of this assay, the Microsuspension
mutagenicity assay (23), have been the
mostwidely used bioassays for this purpose.
In some cases, these bioassays have been
used as an alternative to chemical charac-
terization as an effective approach to com-
pare samples collected from different parts
ofthe world and to track seasonal changes
in the mutagenic character of ambient air
samples. For example, the mutagenicity of
particle extracts per unit volume of air
increases substantially in wintertime
because of residential heating, increased
emissions from colder engines, and changes
in climatic conditions. These measure-
ments suggest that the relative risk increas-
es during this time of the year (24).
Samples can thus be selected during these
periods for further chemical and biological
characterization.
There has been an increasing interest in
semivolatile organic species. Recent smog
chamber and atmospheric studies suggest
that these semivolatile species may be
responsible for a substantial fraction ofthe
Salmonella mutagenic activity of urban air
particle extracts (25,26). Much of the
work presently being carried out does not
indicate a concern for human health risks
associated with exposure to the semivolatile
species; however, further studies are needed
to better understand the health impact of
exposure to these chemical entities.
Volume 102, Supplement4, October 1994 195MOLLERETAL.
SourceApportionment
Substantial progress has been made on the
development of chemical and biological
measurement techniques for the source
apportionment of urban-air toxic com-
pounds and mutagenic activity in urban
areas (27). For example, the extractable
organic matter (EOM), containing POM
and mutagenic activity, was apportioned
for Boise, Idaho, USA, (28,29) and
Gothenburg, Sweden (30) (Figure 3).
The measurement ofradiocarbon C in
air pollutant samples has become accepted
as an excellent method to distinguish
between sources of air toxics derived from
fossil fuel combustion and biogenic sources
(e.g., wood combustion products and
atmospheric reaction products ofterpenes).
Contemporary carbon sources (e.g., wood,
paper) and fossil carbon (e.g., coal, oil)
contain different levels ofl C. Because the
combustion products ofthese fuels contain
the same level of14C as the original fuel,
measurement of the ratio of 14C to stable
13C or 12C in environmental samples can
be used as a source apportionment method.
Analytical techniques are available now
that can make accurate 14C measurements
on a few pg of material (27). The avail-
ability of these improved techniques will
make it possible to source apportion classes
ofpotentially toxic species (e.g., PAH con-
taining liquid chromatographic fractions)
that are present in airpollution samples.
Emission rates for several PAH have
been determined by comparison of their
concentrations near roadways and for HC,
CO, and NO in vehicle tunnels. Some of
these compounds appear to be useful as
markers for diesel and gasoline vehicles.
For example, benzonaphthathiophene has
been used as a tracer for diesel vehicle emis-
sions. However, care must be taken to
ensure that variables, such as changes in
fuel composition and engine operating
conditions, are appropriately considered in
estimating emission rates (31,32).
Multivariate statistical methods have
proven valuable for the analyses of such
variables (33).
Emissions Control
In some parts of the world, the primary
approach to mobile and stationary source
emissions control in the 1970s was to add
control devices such as catalysts, incinera-
tors, scrubbers, and particle collection sys-
tems. However, during the past decade, an
increased effort has been placed on process
modification to reduce emissions.
Examples of process modification include
the use of reformulated fuels, monomolec-
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Figure 3. Source apportionment of emissions for Albuquerque, New Mexico, United States (26), and Gothenburg,
Sweden.
ular fuels (e.g., pure ethanol or hydrogen),
biogenerated fuels (e.g., rapeseed oil),
advanced engine and power plant designs,
on-line combustion process control using
pollutant sensors and computers, materials
substitution, and modification ofindustrial
chemical processes. In addition, regulatory
approaches to emissions reduction are
changing; command and control approach-
es are being (in some cases) replaced with
economic incentives and public/private
cooperation (34).
In the late 1980s, U.S. companies and
regulatory agencies initiated several cooper-
ative environmental research programs.
One of these programs, known as the
Auto/Oil Air Quality Improvement
Research Program, involved a $40 million
effort to develop a reformulated gasoline
(10,35). This extensive program allowed
representative testing of a large number of
vehicles with many different fuels. Such
comprehensive studies are necessary for
understanding the emissions from complex
multivariant systems.
A number ofrecent laboratory andvehide
studies have demonstrated that reformulated
gasoline and diesel fuels can reduce vehicle
emissions (10,32,35). Chemometric
methods using multivariate statistical and
clustering analysis have been used success-
fully to understand relationships between
fuel composition and emissions (32,
35-37). As a result, reformulated gaso-
lines have been introduced in the United
States and in Sweden. Environmental fuels
include low-sulfur (10 ppm S) diesel fuels
as well as reformulated lead-free fuel.
New control methods for diesel vehicles,
including engine modifications and new
exhaust after treatment methods, have
shown the capacity for substantially reduc-
ing the emission ofparticulates, POM, and
mutagenic material (36-38). The environ-
mental acceptability of light-duty diesel
vehicles needs to be reassessed in view of
these reduced emission levels. Such a view
also should consider the effect of the
potential effect of the diesel engine on
reduced regional levels of ozone, carbon
monoxide, gas-phase toxic compounds,
and greenhouse gas emissions.
Legislation was enacted recently in the
United States, Europe, and regions that
require the further reduction of vehicle
emissions to improve air quality. As vehi-
cle emissions are reduced through the
introduction of advanced technology vehi-
cles, and reformulated and alternative fuels,
emissions from malfunctioning and high-
mileage vehicles will become the predomi-
nant sources ofmobile source emissions.
Introduction of reformulated fuels and
emission control devices will continue to
dramatically reduce the contribution from
fossil-fuel powered vehicles to urban air
pollution. However, this new technology
is not available to all parts of the world,
and urban air pollution will remain a
health problem in megacities and heavily
industrialized areas.
Recommendations
Although a significant effort was undertak-
en during the past decade to collect and
measure organic species in ambient and
interior air samples, there still exists signifi-
cant gaps in several areas. The Work
Group formulated recommendations in
several key areas: a) Develop methods that
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can be used to assess more accurately the
relative contribution ofemissions from var-
ious indoor and outdoor sources. b)
Update emission inventories from mobile
and stationary sources on a regular basis.
c) Develop a statistically robust data base
for VOCs, SVOCs, and POMs for high-
mileage and malfunctioning vehicles. d)
Determine the relative importance of bio-
genic to anthropogenic sources of photo-
chemically reactive organic species for a
number of urban areas throughout the
world. e) Identify and assess the ozone-
and particle-forming potential ofspecies in
the SVOC phase (e.g., in diesel emissions).
f) Establish an international geographic
information system to combine environ-
mental data about air, water and soil to
better understand the natural interactions
of pollutants between these media and to
highlight areas of environmental interest
and concern. g) Develop improved urban
air shed models to help identify the com-
plex situations and potential trends in the
future. Undertake ambient air monitoring
studies to validate model assumptions and
parameters. h) Expand international col-
laborative efforts between industry and
government organizations to undertake
research efforts on the development oflow-
cost and effective emissions control strate-
gies. i) Initiate a collaborative effort to
develop a reformulated diesel fuel in
Europe because there is a significant pro-
portion ofdiesel vehicles in these countries.
j) Undertake fundamental studies on com-
bustion processes that are capable ofdevel-
oping models that can accurately predict
the effects of fuel changes, engine design,
and various control strategies on vehicle
emissions.
Atmospheric Transport
and Chemistry
Once introduced into the atmosphere,
chemical species in both the gas and parti-
cle phases are subjected to transport
processes, including wet and dry deposition
(39). Atmospheric reactions most likely
will occur that influence the ultimate
chemical composition to which human
populations are exposed (40).
Organic compounds are removed from
the atmosphere by wet and dry deposition;
photolysis; and reaction with hydroxyl rad-
icals, nitrogen trioxide (NO3 ) radicals,
and ozone (39,41,42). For the majority of
organic chemicals (excluding methane,
ethane, and certain haloalkanes), the
expected atmospheric lifetimes are estimat-
ed to range from a few hours to 10 to 20
days (43). Chemical reactions lead to the
formation ofmore polar products that can
undergo gas-to-particle conversion (44),
such as the formation of particle-phase
nitro-PAH from reactions of gas-phase
PAH (45).
A knowledge of these reaction products
is needed to assess exposure ofhuman pop-
ulations. These physical and chemical
processes depend on meteorology and
chemical reactions that can lead to the for-
mation as well as the removal oftoxic com-
pounds. Therefore, these atmospheric
removal and transformation processes link
emissions and exposure.
VolateOrganicCompounds
The chemical reactions ofeach VOC with
nitrogen oxides in the atmosphere have dif-
ferent reaction mechanisms and rates.
These reactions lead to the formation of
ozone and the degradation of VOCs with
the concurrent formation of a myriad of
reaction products including mutagenic
components (45,46,47).
A great deal ofwork has been undertak-
en during the past few years to develop
simplified methods to calculate the ozone-
forming potential of emissions from vari-
ous sources (43). Such methods have been
enhanced greatly by a more complete
understanding of the reactive hydrocarbon
species that are present in emissions and an
improved understanding ofozone and oxi-
dant formation mechanisms (48).
Presently, our knowledge concerning the
products formed from the atmospheric
reaction of organic compounds is insuffi-
cient. Even for such important volatile
organic compounds (VOCs) as benzene,
toluene, and the xylenes, only about halfof
the product mass has been accounted for
(49,50). Identification of the remaining
products is difficult because they are labile
and polar. The uncertainties in the atmos-
pheric chemical reactions for the VOCs, in
combination with corresponding uncer-
tainties in airshed model predictions, leads
to a lack ofknowledge of the amount and
identity of potentially toxic products
(51,52).
SemivolatileOrganicCompounds
SVOCs are present in ambient air as gases
and associated with particulate matter.
The distribution of SVOCs between the
gas and particle phases controls their
removal from the atmosphere by physical
(e.g., wet and dry deposition) and chemical
and photochemical processes (53).
Studies initiated in the late 1980s
demonstrated that the Salmonella muta-
genicity of SVOCs in urban ambient air
samples can be as high (per unit volume of
air collected) as that for the solvent extracts
from particles (24,25,54). Concurrent
laboratory studies have demonstrated that
SVOCs can be converted to gas and parti-
cle phase components, the products of
which are mutagenic.
Most of these mutagenic products
appear to be derived from the atmospheric
reaction ofgas-phase aromatic and polynu-
clear aromatic hydrocarbons (PAH) and
PAH derivatives (e.g., methoxypyrene).
Recent smog chamber experiments and
ambient measurements suggest that atmos-
pheric reaction products of 2- to 4-ring
PAH account for a substantial fraction of
the mutagenic activity in urban air (45).
These reaction products consist ofvarious
nitrated products. A major portion of
these PAH reaction products remain
unidentified, and the potential health risks
associatedwith these species are unknown.
PolycyclicOrganicMaterial
POM occurs in the atmosphere primarily
as organic compounds adsorbed on the
inorganic particle matrix (55). The poly-
cyclic aromatic hydrocarbons (PAH) are
present at parts per million levels in the
particles. The four-ring PAH (fluoran-
thene and pyrene) are distributed between
the gaseous and particulate phases.
Benzo[a]pyrene (B[a]P, five rings) is only
found in the POM phase. B[a]P repre-
sents approximately 4% of the total POM
in most combustion-derived particle emis-
sions.
At the 1983 workshop (56), consider-
able attention centered on the presence of
PAH-derivatives in POM such as nitrated-
PAH (nitro-PAH). Since that time, an
international research effort has been
directed toward understanding the abun-
dance, sources, and atmospheric chemistry
ofthese PAH derivatives as well as the pos-
sible human health effects associated with
exposure to these compounds. An example
of such a study was undertaken by the
International Agency for Research on
Cancer (IARC) (57) that summarizes the
evaluation of the carcinogenic potential of
15 different nitro-PAHs.
Air QualityModes
The process ofdispersion and deposition of
nonreactive air pollutants (e.g., CO,
methane [CH4]) is relatively well under-
stood (58). However, this is not the case
for reactive species (e.g., toluene).
Advanced photochemical air models calcu-
late the evolution ofpollutants by accurate-
ly describing the physical and chemical
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processes responsible for the chemical
transformation, transport, and fate of pol-
lutants in the atmosphere. These models
use fundamental meteorological parameters
such as wind speed, wind direction, relative
humidity, and temperature gradients
(inversion layers, mixing heights).
Different dispersion models have been
developed for different geographical scales
(e.g., continental, nationwide, regional,
urban, and local).
These models are being used increasingly
as the basis for determining the effective-
ness of proposed pollution control strate-
gies in advance ofthe adoption ofparticu-
late emission controls. Thus, they are the
most scientifically sound foundation for
testing the relative effectiveness of alterna-
tive emission controls. They also serve as
the basis for policy decisions that must be
made between alternative programs
designed to improve air quality.
A thorough evaluation of predictions
and observations is critical for assessing the
performance ofphotochemical models and
providing a basis for confidence in a
model's use. Historically, because ofa lack
ofmeasurements, model data sets have suf-
fered from significant gaps in the knowl-
edge of the prevailing meteorology, emis-
sions, and air quality. The Southern
California Air Quality Study (SCAQS) was
conducted in the Los Angeles area during
1987 to help in this regard (59). The data
from this study have provided a much
more comprehensive set of measurements
with which to test urban-scale photochemi-
cal models.
Recommendations
Research studies during the past decade
have demonstrated that atmospheric chem-
istry plays a critical role in the formation
and degradation of toxic substances.
However, it is not known which atmos-
pheric reaction products could have a
potential positive or negative impact on
human health. Further work is needed to
a) obtain updated mobile-source and man-
ufacturing emission factors for gas- and
particle-phase hydrocarbons on a regular
basis; b) to determine the key gas- and par-
ticle-phase atmospheric reactions that affect
the formation and degradation of toxic
species in ambient air; c) to develop
improved analytical techniques for identi-
fying the polar-, labile-, and low-volatility
atmospheric reaction products; d) to iden-
tify the major mutagenic and carcinogenic
products from the atmospheric reactions of
HCs and PAH with NOX; e) study the
atmospheric transformations of vehicle
Table 2. Some representative (indicator) compounds that are present in the VOC, SVOC, and POM phases of
ambient air pollutants.
Air pollutant phase Representative compounds
Volatile organic compounds (VOCs) Benzene, toluene, 1,3-butadiene, formaldehyde
Semi-volatile organic compounds (SVOCs) Naphthalene, 1-nitronaphthalene, pyrene, 2-nitrofluorene
Respirable particles Elemental carbon, lead
Polycyclic organic material (POM) Benzo[a]pyrene, 1-nitropyrene
Gas-phase inorganics CO, NOX, SO2
Abbreviations: CO, carbon monoxide; NOX, nitrogen oxide; SO2, sulfur dioxide; Pb, lead.
exhaust with respect to chemical products
and the potential biological effects ofthese
products; and f) to reassess the relative
importance ofgas versus particle phase pol-
lutants in terms ofhuman health effects.
Large-scale air quality studies similar to
the SCAQS study need to be carried out for
major urban areas such as Mexico City,
New York, and Cairo in order to provide a
comprehensive set of measurements with
which to test urban-scale photochemical
models. Advanced models will need to be
developed that link microscale and
mesoscale dispersion equations (e.g., com-
bine street canyon and urban dispersion
models). Finally, these models will need to
incorporate the chemical and physical
atmospheric processes that affect the pres-
ence oftoxic compounds.
Exposure Levels
Epidemiological data for humans exposed
to high levels of air pollutants (e.g., coke
oven workers) support the role ofair pollu-
tion in human lung cancer (60). A few
studies on populations living in urban
environments have shown a weak correla-
tion between cancer and air pollution.
However, because detailed measurements
of exposure levels were not performed and
because of the presence of several con-
founding factors, there is considerable
uncertainty about the quantification ofthe
effects because of ambient air pollution as
an etiological factor. It is ofimportance to
consider different localizations of cancer
because inhaled materials can undergo sys-
temic circulation after absorption into
blood. In addition, a large portion of
inhaled material is swallowed because of
muco-ciliar transport from the lung or
absorption in the upper respiratory tract.
Exposure may be estimated through sur-
veys or quantitatively through ambient
monitoring, personal monitoring, or bio-
logical monitoring. The development of
improved methods to accurately assess
human exposure to air pollutants has been
an area of active research during the past
decade. It has become increasingly recog-
nized that an accurate assessment of expo-
sure is difficult to achieve but ultimately
necessary ifmeaningful risk assessments are
to be done. Integrated exposure depends
upon the magnitude ofexposure, the dura-
tion of exposure, and the level of human
activity.
An alternative approach is to use air
quality models, which are based upon
detailed emissions inventories, meteorolo-
gy, atmospheric chemical processes, and
other complex parameters. The models
can be used to calculate the concentrations,
with the inclusion ofpollutants chemically
formed in the atmosphere, in different
microenvironments where human beings
can be expected to spend a significant por-
tion of their time in homes and offices;
walking, running, or riding bicycles near
busy roads and heavy industrial areas; or
inside plant environments and other
microenvironments. Thus, human expo-
sure can be estimated by many kinds of
measurements and by model calculations,
including air quality and activity data. A
combination of the two approaches seems
to be the most efficient.
Since the 1960s, most measurements of
urban air pollutants have been obtained
using fixed station measurements of total
particle mass, sulfur dioxide (SO2), NOx,
CO, hydrocarbons, and ozone. Ambient
monitoring neglects spatial and indoor and
outdoor concentration differences and may
lead to significant misclassification ofexpo-
sure.
Current research focused on the identifi-
cation ofselected chemical species or class-
es ofspecies that could be measured to rep-
resent exposure to complex mixtures of air
pollutants. Some examples of indicator
substances are given in Table 2. Carbon
monoxide and nitrogen oxides have served
as good indicator substances for vehicle
emissions (58).
Benzo[a]pyrene (B[a]P) was suggested
over three decades ago as an indicator sub-
stance to help assess exposure to air toxics
(61). As a result, a substantial data base
for B[a]P has been acquired in source
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emission and ambient air samples (62).
Although B[a]P is one ofthe most chemi-
cally reactive PAHs, this compound will
continue to be an important marker of
human exposure to air toxics, particularly
for studies of long-term trends. Such use
of B[a]P data bases requires, however, an
evaluation of the analytical methods used
in past studies. Proper care should be
taken to minimize degradation of B[a]P
during sampling, storage, and analysis. It
is recommended that measurement of
B[a]P and benzo[e]pyrene ratios be deter-
mined to assess if significant loss of B[a]P
has occurred (31). Efforts should be
undertaken to determine whether a better
indicator substance can be identified.
Our increased knowledge base on the
qualitative and quantitative distribution of
air pollutants is being used to predict the
formation ofozone and to identify and val-
idate the use of indicator substances to
determine the presence of other compo-
nents (43).
There are many locations in the world
where economic constraints have limited
the establishment of extensive sampling
networks and analytical environmental lab-
oratories. Therefore, it is very important to
carry out studies that can be used to identi-
fy easily measured atmospheric constituents
or groups ofcomponents that are ofspecial
interest from the health effects point of
view and that can serve as a base set to
assess pollution levels and human expo-
sures.
It is essential in selecting or calibrating a
specific measurement technique to be con-
scious ofother data to which the measure-
ment will be compared. For example, epi-
demiologic studies use relationships
between exposure measurements and dis-
ease incidence. The exposure level to the
selected population group is estimated
from fixed sampling sites. These data are
used in a manner that assumes that the
constituents and the concentration of con-
stituents do not change over many years of
exposure.
Total Integrated PersonalExposure
An accurate assessment ofhuman exposure
to toxic air pollutants has been difficult to
obtain. Because there are wide variations
in exposure levels within an urban area,
there has been a trend to increase the num-
ber of fixed urban sampling sites, collect
samples more frequently, and generate
more detailed chemical composition data
on the atmospheric pollutants. This trend
has been necessary in order to generate a
better estimate of the actual exposure of
urban populations to localized sources
(e.g., homes near roadways and municipal
incinerators) (63). In addition, an
increased effort has been undertaken to col-
lect samples in other areas where people
may spend a significant portion of daily
activity.
Indoor air exposure also plays an impor-
tant role in determining total exposure to
B[a]P. Jenkins et al. (64) reported that
the average adult Californian spends nearly
62% of the time at home, where exposure
to B[a]P and other pollutants may occur at
levels well above the typical ambient air
exposure the individual may encounter.
The B[a]P exposure indoors can range
from about five times up to several hun-
dred times higher than the dose received
outdoors.
The data that are derived from exposure
measurements often have a high level of
uncertainty. In general, the mean exposure
outdoors, as determined from fixed moni-
toring stations, gives good agreement with
personal samplers, but the variation is
greater, which can lead to a poor estima-
tion ofthe exposure. In any case, the ques-
tion must be raised as to how accurate the
exposure measurement should be made.
The accuracy of actual assessments of
exposure to response relationship is depen-
dent upon the reliability of measurements
of exposure levels as determined from the
ambient air monitoring technique. Each
sampling technique that is further removed
from the target tissue will yield a less accu-
rate assessment ofdose. The least represen-
tative samples are derived from fixed sam-
pling sites.
Personal Monitors
Currently, personal air sampling monitors
provide the most accurate measurements of
daily exposure to air toxics. However, it is
not practical to use personal monitors to
collect 24-hr ambient air samples. A recent
Swedish study demonstrated how a personal
NOx monitor was used to identify an
unknown source ofhigh NOxexposure for
children. On normal days, the NO expo-
sure was low, but some days these children
had extremely high NOx exposure. It was
found that these children were all exposed
to high levels when they visited ice hockey
rinks. The ice was prepared with propane-
fueled ice-resurfacing machines and the air
exchange rate was low, which led to very
highNO, levels (65).
ExosureModels
Numerous models have been developed
and applied to an estimation of human
exposure from airborne materials (66).
The aggregate risk to human health from
exposure to an airborne pollutant results
from the characteristics of the agent's
action on the people who are exposed to it.
The useful expression of the risk depends
on joint statistical considerations of agent
dispersion and characteristics ofthe human
receptors. The aggregate risk also results
from the spread of the primary agent (and
its transformation products) from its
source(s) to contactwith people.
Current exposure models take into
account the interaction between each ofthe
main risk analysis elements. Exposure esti-
mates result from the integration ofpollu-
tant dispersion patterns and human popu-
lation patterns. The dispersion patterns, in
turn, result from the joint action of emis-
sions and dispersion processes.
It is presumed that the effect ofcarcino-
genic materials is to produce critical cell
damage. Thus, carcinogenic health effects
models, in general, are dose (e.g., integrated
exposure) models, not exposure models.
The lack offirm statistical bases often leads
to the adoption of nonthreshold, linear
models, even in cases where thresholds and
nonlinear effects might be expected.
If linear (dose) models without thresh-
olds are to be used for carcinogen (or
other) risk assessments, estimation ofexpo-
sure at specified levels becomes irrelevant
to risk assessment or, at least, its use is non-
intuitive. For example, a carcinogen risk
analysis may be based on a linear, non-
threshold health effects model. The total
collective health riskwould thus be propor-
tional to the long-term exposure summed
for all affected people for the identified
period, and exposure of many people at
low concentrations would be equivalent to
exposure of a few to high concentrations.
The atmospheric dispersion that reduces
concentrations also would lead to exposure
of more people; therefore, increments to
population risk would not necessarily
diminish with increasing dispersion time or
distance. Limits to human risk would only
exist if the concentration or population
patterns were bound, for example, by either
chemical decay or scavenging by such phe-
nomena as precipitation and respiration.
It is important in defining any modeling
scheme that the analytical elements be con-
sistent in scope, scale, and detail with each
other and with the purposes ofthe analysis.
It appears that microenvironments are
clearly important in carbon monoxide
exposure analysis because automobile-gen-
erated CO concentrations are highly corre-
lated with automobile usage patterns.
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Figure 4. A systems approach for evaluating and reducing the potential health risks from exposure to urban air pollutants (courtesy of Charles Powers, Health Effects Institute).
However, it is not clear if ozone exposures
are so correlated.
Considering the large number of com-
pounds in ambient air and the economic
and practical impossibility ofroutine analy-
sis for more than a few of them, it is
important to select suitable indicator com-
pounds and to establish the relative con-
centrations with the indicator as references,
in specific analyses of many compounds.
This should be done at the emission level
as well as in ambient air. Researchers
working in the areas ofindoor and ambient
air have begun only recently to work
together. Many pollutants in these two
environments are the same, and it is neces-
sary to assess exposure to both environ-
ments. In addition, the exposure of
humans to air toxics needs to be kept in
perspective with respect to exposure from
other sources such as food, water, drugs,
etc. Thus, it is necessary for scientists
working in each of these areas to work
more closely together.
Rommentions
One of the greatest research challenges of
the next decade will be how to accurately
assess true exposure to air toxics and assess
the composite risk associated with exposure
to complex mixtures. Specific research rec-
ommendations to help meet this task
include the following: a) Identify selected
compounds or groups of compounds that
can be easily measured to better assess inte-
grated human exposure to toxic air pollu-
tants. b) Determine relationships between
more precise measurement techniques and
those that can yield information from
remote locations (e.g., satellite measure-
ments). c) Increase collaboration between
researchers working in the areas of indoor
and ambient air pollution. d) Obtain bet-
ter quantification of population activity
patterns in order to provide a basis for
accurate exposure calculations. e) Develop
further personal monitoring techniques to
provide the information necessary for the
validation ofdeterministic and probabilistic
models.
Risk Identification
The accurate assessment ofpotential health
risks associated with exposure to air pollu-
tants is a highly complex process that
requires the systematic integration of the
many basic components that have been
described in the previous sections and illus-
trated in Figure 4.
Risk identification consists ofthe qualita-
tive evaluation of data from epidemiologic
studies, physical and chemical studies,
short-term bioassays, animal exposure stud-
ies and molecular biology techniques such
as metabolic studies, and structure-activity
investigations.
In addition to cancer, there are other
noncancer health effects ofurban air pollu-
tion that may be of more public health
importance. Although classical risk assess-
ments generally focus on cancer, the con-
sideration of many noncancer end points
such as asthma, respiratory infections,
bronchial distress, allergies, and other pul-
monary problems that may be associated
with urban air pollution will continue to be
needed. Application ofchemical analytical
methods to study the molecular basis for
these conditions could shed light on the
possible role that certain air pollutants may
play in the causation or aggravation of
these health problems.
Nearly all chemicals that are ingested by
animals undergo biotransformation.
Biotransformation is frequently a critical
determinant of the toxic and carcinogenic
effectiveness of chemicals, because animals
metabolize chemicals to more toxic or car-
cinogenic species (activation) or to less
toxic or carcinogenic species (detoxication).
Thus, the ultimate carcinogenic species of a
chemical is often a metabolite rather than
the parent compound. It is now known
that this can lead to significant nonlineari-
ties in the cancer dose-response relation-
ship because many metabolic enzymes fol-
low hyperbolic kinetics. At high doses of a
chemical, saturation of metabolism can
occur. This can serve to limit the amount
of carcinogenic metabolite produced, or it
can limit the capacity of the animal to
detoxicate a carcinogenic species.
Toxicity data are available on only a
small number ofair pollutants. This neces-
sitates estimation of the health effects for
most of the compounds from information
acquired in cellular or laboratory animal
studies. Another issue is that the risks at low
levels of exposure typical of environmental
situations must be extrapolated from studies
conducted at higher exposure levels.
Pure Compounds versus
Complex Mixtur
An assessment of the potential health risks
associated with exposure to complex mix-
tures requires more than an understanding
and quantification ofthe effects ofindivid-
ual compounds present in the mixture.
Clearly, in a mixture ofthousands of com-
pounds, there is a great deal ofpotential for
interactive effects among different compo-
nents. While the toxicity of a mixture can-
not be understood solely by an assessment
of the effects of individual compounds, it
also is true that it is not possible to assess
the toxicity of all possible combinations of
these compounds. Some approaches are
being developed to understand synergistic
actions by comparing the observed lethality
of mixtures to the predicted lethality of
these same mixtures using an additive
model for prediction (67). However, such
methodologies require an extensive level of
testing. Thus, it will be important to find
new approaches to addressing the toxicity
ofmixtures.
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IARC describes the problem with com-
plex mixtures in the following way:
Estimating the human cancer risks ofexpo-
sure to complex mixtures presents formida-
ble methodological problems. However,
such exposures are thought to account for a
large proportion of cancers, in particular
because ofwidespread exposure to such mix-
tures within populations (68).
Since the early 1970s, several govern-
ment organizations such as the U.S.
National Institute of Standards and
Technology (NIST), the U.S. National
Cancer Institute, and other organizations
have made available small quantities of
chemical reference materials for environ-
mental studies. These reference materials
have been distributed as pure compounds
in solid state or solutions or as mixtures of
pure compounds in solution at specified
concentrations.
During the 1980s, NIST developed
standard reference materials (SRM) that
represent complex mixtures of environ-
mental samples. These samples included
two ambient air samples (SRM 1648 and
SRM 1649), a heavy-duty diesel particulate
sample (SRM 1650), and a coal tar sample
(SRM 1597) (69).
In 1987, the International Program on
Chemical Safety, in collaboration with the
EPA and NIST, initiated an international
collaborative study on the mutagenicity of
complex environmental mixtures in the
Ames assay. This study determined the
inter and intralaboratory variability associ-
ated with the extraction and bioassay ofthe
SRMs 1597, 1649, and 1650. It was
found that these SRMs provided useful
materials for bioassay studies, in much the
same way these reference materials have
been valuable for developing methodolo-
gies for the measurement ofspecific chemi-
cal species in these mixtures (70).
An International Symposium on
Biological and Environmental Reference
Materials (BERM) was held in Aachen,
Germany, during the same month as this
workshop. The BERM also concluded that
the use of biological and environmental
reference materials are essential for meeting
the goals ofcompatibility and comparability
in environmental measurement. Thus, it is
expected that complex mixture SRMs will
play an increasingly valuable role for the
development of chemical and biological
assay techniques, for standardizing and
comparing procedures used in laboratories,
worldwide, and to support fundamental
studies on synergistic and antagonistic bio-
logical effects.
Short-Term Bioassays
Short-term bioassays have been used exten-
sively to compare the total mutagenic activ-
ity of samples collected from various
sources and ambient air (71,72). The
Salmonella mutagenicity assay has been
used to demonstrate that most air samples
exhibit mutagenic activity. This assay has
been used as a fundamental tool to help in
identifying the major chemical species
responsible for the mutagenic activity of
urban air particulate matter. The ease of
carrying out this bioassay has focused
research activities on the mutagenic activity
of urban air emissions, while ignoring
many other types of genetic end points.
Since the 1982 meeting in Stockholm,
more than 100 papers dealing with the
mutagenicity of complex mixtures extract-
ed from airborne particulate matter have
been published. Several of these papers
describe a good correlation between the
presence of a particular class of pollutants
and mutagenicity (68). This large body of
data has made it possible to rank rural,
industrial, and urban areas all over the
world in terms ofmutagenic activity; taking
into account modifying factors such as
temperature, wind direction, etc. (23).
There is now available a wide array of
short-term bioassays that are being used to
identify the potential risk associated with
exposure to air toxics. Such bioassays
include the dioxin-receptor ligand assay
(73), the HPRT locus assay (74), and oth-
ers. The combination of these bioassays
with the generation of mutational spectra
has extended the dimensionality of such
tests (74). DeMarini (75) has used the
Salmonella (TA98) assay in combination
with colony probe hybridization to detect a
common hotspot deletion, followed by
polymerase chain-reaction (PCR) and
DNA sequencing, to generate mutation
spectra. This exciting new technique sug-
gests that unique mutation spectra can be
generated by different classes of complex
mixtures and that such spectra are a conse-
quence of the dominance of a particular
chemical class or dasseswithin the mixture.
Since the early 1980s, several investiga-
tors have used bioassay-directed chemical
fractionation and bioassay-directed chemi-
cal analysis to facilitate the identification of
potentially important chemical mutagens
in complex environmental samples.
Current studies have focused on the identi-
fication ofoxygenated and nitrated PAH in
polar chemical fractions (22,24,76,77). A
number of highly mutagenic chemical
species have now been identified induding
3-nitro-6-azabenzo[a]pyrene-N-oxide
(77), nitrodibenzopyranones (45), and
nitro-hydroxy-PAH (78).
Mutagenic activity in the gas-phase may
not be as important as the presence of
mutagenic activity in particulates because
of the pharmacokinetics (i.e., uptake, dis-
tribution and metabolism) of the active
material. Short-term assays, such as the
Ames test, are a valuable tool for identify-
ing risk factors; but it is of importance to
note that the enormous difference in bacte-
rial mutagenicity for nitro-PAHs (a factor
of approximately 100,000) is not seen in
vivo. It is therefore of importance to gain
understanding on the mechanisms to
explain these differences.
Animal ExposureStudies
A number ofcomprehensive animal inhala-
tion studies were carried out in the mid-
1980s in the United States, Japan, and
Germany, which demonstrated that rats
exposed by inhalation to diesel exhaust
developed lung tumors, whereas those
exposed to filtered diesel exhaust did not.
It was the consensus opinion of a meeting
held in Tsukuba, Japan, in 1986 that these
tumors were caused by carcinogenic organic
compounds associated with the particles
(79).
The results of the animal cancer tests
and epidemiology studies, together with
the assumption that the tumors were
caused by the organic compounds, were
used by the EPA and other agencies (80)
to conclude that diesel exhaust is a proba-
ble human carcinogen, and the potencies
observed in the animal studies were used as
a basis for estimating the human cancer
riskofdiesel exhaust.
The animals were exposed generally to
concentrations of diesel particles that were
much higher than those found in ambient
air. At these very high particle loadings,
the animals lungs became burdened with so
much particulate matter that some investi-
gators hypothesized that the lung tumors
were not caused by the organic material
associated with the particles, but rather
they were because of the particles them-
selves, causing tumors by mechanisms
related to chronic irritation, cell prolifera-
tion, and localized cell killing (81).
Studies were carried out by the Lovelace
Inhalation Toxicology Research and
Fraunhofer Institutes in the late 1980s to
determine if the inhalation of particles
without absorbed organic material could
cause tumors. In these experiments, ani-
mals were exposed to carbon black and
titanium dioxide particles that mimicked
diesel particles in size distribution, surface
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area, and aerodynamic properties. These
studies demonstrated that these particles
caused tumors in animals at rates compara-
ble to those observed in the previous diesel-
exposure experiments (82). Thus, it can
be suggested that the particle loading can
help explain the incidence of tumors
observed in the mid-1980s from animal
cancer tests of diesel exhaust. Previously,
similar conclusions have been drawn from
instillation experiments with particles of
different composition (83,84). Further
work is needed to understand the mecha-
nisms of these effects. The surface area of
the carbon black particles is much greater
than the diesel particles if the surface area
of the diesel particles is measured with the
organics adsorbed (as they are inhaled).
Because the surface area ofparticles is cor-
related with the carcinogenicity ofparticles,
then it is possible that in the case ofcarbon
black the tumors are induced primarily by
a phenomena associated with the particle
surface, whereas the tumor response from
inhalation of diesel particles could be a
combination of induced mutations by the
organics and by the particle surface. It will
be difficult to determine if there is a
threshold in the dose-response for carcino-
genicity associated with exposure to these
particles. The significance of these results
relative to human risk assessment is uncer-
tain, but the results indicate that efforts to
reduce both particle emissions and emis-
sions of genotoxic substances could be of
importance as risk-reducing measures.
These studies and others have shown
that animal studies have been very useful
for identifying hazards from toxic materials
(85). The identification ofa health effect,
such as cancer in animals, provides a warn-
ing that the agent tested has the potential
for causing a similar effect in humans.
However, caution must be used in deriving
numerical risk factors from animal data for
predicting the incidence ofhealth effects in
humans.
Animal bioassays intended to explore
human health effects expected to occur after
chronic exposures, or at late ages, must
include observations ofthe animals for their
life span. In some cases, the typical ending
of the observation time (such as at 2 years
for the rats) may truncate the development
ofeffects and the significance oflate-occur-
ring effects may not be appreciated.
In the past decade, substantial progress
has been made in using physiologically
based pharmacokinetic models to under-
stand exposure-dose relationships for a
number ofchemicals in laboratory animals
and their extrapolation to humans. There
still remain many questions concerning the
extrapolation ofrisk from the animal to the
human case. This is especially true for
noncancer effects. Understandingly, the
mechanisms by which the health effect is
produced is a key to these extrapolations.
Research is progressively revealing the indi-
vidual events or steps leading to the expres-
sion ofthe disease.
A major issue is the high degree of
uncertainty associated with such extrapola-
tions. The composite level of uncertainty
is the result ofaccumulated uncertainties in
manyvariables including the exposure con-
ditions (exposure route, tissue dose, etc.),
extrapolation from high to low dose, repair
mechanisms, synergism, antagonism, and
others.
IndividualSusceptibility
Although many individuals come in con-
tact with environmental pollutants, only a
limited number ofthese exposures result in
a pathophysiologic response. In assessing
the risk from exposure to urban air pollu-
tion in various parts of the world, it is
important to consider if any particular
groups may be more susceptible than others.
Air quality standards often are related to
high-risk groups, such as children, elderly,
people with pulmonary diseases or allergies,
etc. Thesegroups might requirelowerlimits.
Significant biological variability has been
demonstrated in the airway response to a
number of environmental exposures (86).
The difference in disease response may be a
function of genetic factors and exposure
levels.
For each category of pollutants, the
acute and chronic health effects under vari-
ous exposure conditions should be investi-
gated. For all these effects, it is important
to consider what groups might be the most
susceptible or the most exposed. In addi-
tion to genetic differences, dietary differ-
ences, preexisting disease, age, gender, life
style or exposure to other pollutants may
affect the susceptibility to particular envi-
ronmental pollutants. Pulmonary condi-
tions (e.g., infections, asthma, chronic
bronchitis) may affect susceptibility in
some instances.
Several studies have indicated that there
may be an inherited susceptibility to cer-
tain types of cancer. Genetic differences
among individuals may potentially affect
their susceptibility to the carcinogenic
effects of inhaled chemical toxicants. A
few studies have pointed to an association
between certain metabolic phenotypes and
risk for lung cancer or bladder cancer.
These variations include the activities of
enzymes involved in the metabolism of
environmental genotoxins (e.g., members
ofthe cytochrome P450 family ofenzymes
and glutathione transferase) in repair of
DNA lesions. In addition, dietary factors
as well as factors present in air pollution
can influence the expression of these
enzymes. The level of activity of these
enzymes will influence the effective target
dose. A genetic polymorphism could serve
as marker(s) for increased susceptibility
without necessarily being directly involved
in the carcinogenic process. A number of
other biological processes (e.g., increased
cell turnover because of inflammatory
responses and changes in immune system
function) also may influence the carcino-
genic process.
Clinical and epidemiological studies
have demonstrated considerable individual
variation in the response to acute exposures
to ozone as measured by pulmonary func-
tion decrements, increases in airway resis-
tance, indicators of an inflammatory
response, and other end points like respira-
tory and nonrespiratory symptoms.
It is important to clarify the interrela-
tionships among the short-term responses
that have been observed, their health signif-
icance, and their potential relevance to the
occurrence of chronic damage after long-
term exposure.
Molecular BiologyTecmhiques
Since the first report by the Urban Air
Committee 10 years ago (3), more mecha-
nistic information has been obtained
regarding the molecular basis for cancer
induction. In particular, the discovery,
characterization and possible role of pro-
tooncogenes and tumor suppressor genes
has provided a critical underpinning for the
mutational basis ofcancer induction. The
recognition of the important role that
mutations in these critical genes may play
in tumorigenesis has provided a renewed
confidence in the validity and utility of
mutational analysis.
The development ofthe PCR and DNA
sequencing techniques now permits the
molecular analysis ofmutations induced in
bacterial as well as eukaryatic systems (75).
It is feasible to sequence mutations induced
by single components, chemical fractions,
and unfractionated urban air samples.
Particular mutational mechanisms are
being identified that may have general
application to eukaryotic organisms,
including humans. With regard to analysis
of mutations in humans, such work
presently is possible only in a limited way.
Because ofthe difficulties ofdistinguishing
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Table 3. Air pollutants that are considered to be car-
cinogenic (group 1), probably carcinogenic (group 2A),
or possibly carcinogenic (group 2B)to humans. a
Pollutant Evaluation
Inorganic substances
Arsenic and arsenic compounds b
Asbestos
Chromium (VI) compounds
Erionite
Nickel compounds
Radon and its decay products
Beryllium and beryllium compounds
Cadmium and cadmium compounds
Silica, crystalline
Antimony trioxide
Ceramic fibers
Glasswool
Lead and lead compounds
Nickel, metallic
Rockwool
Slagwool
Hydrocarbons (HC) and complex HC mixtures
Benzene
Gasoline
Marine diesel fuel
Residual (heavy)fuel oils
PAH and PAH mixtures
Tobacco smoke
Benzo[alanthracene
Benzo[a]pyrene
Benzo[b]fluoranthene
Benzo[f]fluoranthene
Benzo[k]fluoranthene
Dibenzo[a,h]anthracene
Dibenzo[a,elpyrene
Dibenzo[a,h]pyrene
Dibenzo[a,ilpyrene
Dibenzo[a,flpyrene
Indeno[1,2,3-c]pyrene
Nitro-PAH and PAH mixtures
Diesel engine exhaust
Gasoline engine exhaust
1,6-Dinitropyrene
1,8-Dinitropyrene
6-Nitrochrysene
2-Nitrofluorene
1-Nitrofluorene
4-Nitropyrene
Other compounds and mixtures
Soots
Ethylene dibromide
Formaldehyde
2A
2B
2B
2B
2B
2B
2B
2B
PAH, polycyclic aromatic hydrocarbon. a For definitions
of the groups, see IARC, 1987, pages 29-32 (68).
bThis evaluation applies to the group of chemicals as
a whole, and not necessarily to all individual chemicals
within the group.
the control or background mutations from
those that might be induced by environ-
mental pollution, there remain many tech-
nical problems to be solved before such
analyses in humans can be considered rou-
tine. The major emphasis on human stud-
ies should be to examine relevant genes,
such as oncogenes and tumor suppressor
genes.
Since the identification of highly muta-
genic PAH derivatives (e.g., nitrated-PAH)
in particle extracts, numerous studies have
been undertaken to understand the in vivo
metabolism and potential genotoxic effects
ofthese species. At this time, the chemistry
of metabolite formation, the circulation of
these metabolites, and the binding ofthese
metabolites to proteins and DNA have been
characterized (87,88). It will be more diffi-
cult to assess the ultimate health-effects
consequence ofthese chemical processes.
There are a variety of ways in which
molecular techniques can be applied to the
health effects studies of urban air (89).
Integration of laboratory techniques with
epidemiological research strategies is
important in order to perform cancer risk
assessment of exposure to complex mix-
tures. An additional goal ofthe application
ofmolecular techniques to urban air health
effects would be the possible prediction of
health effects for people at risk from expo-
sure to certain pollutants. A holistic view
of urban air pollution would encompass
the use of molecular techniques to analyze
mutational damage induced by urban air
samples in particular environments. Such
analyses could determine whether there
were excess DNA adducts and mutations in
such organisms as compared to those in
other, more pristine, environments (88).
The use of biomarkers for nongenetic end
points is in its infancy and requires exten-
sive new research.
Remounendations
In the last decade, more information on
the carcinogenic process has evolved. New
sensitive analytical methods to assess expo-
sure combined with new information
about carcinogenic potency have increased
the potential for assessment of the health
risk associated with exposure to urban air
components. There are still a number of
areas in which more research is needed: a)
Take advantage of opportunities for inter-
national collaboration in epidemiological
studies, particularly to investigate areas
with heavy exposures such as Cairo,
Mexico City, Beijing, and Eastern Europe.
b) Undertake multinational research stud-
ies, covering different ethnic groups, to
determine the association between genetic
polymorphism in genes that govern the
activation and deactivation oftoxicants. c)
Coordinate an international effort to col-
lect and store selected tissue samples (e.g.,
blood, surgical, or autopsy tissues) from
humans and possibly animals living in pol-
luted environments. d) Undertake a con-
certed effort to collect and store selected air
samples from highly polluted areas for use
in future chemical and biological assays. e)
Collect and validate additional complex
mixture standard reference materials as
needed for environmental tobacco smoke,
ambient air particles from highly polluted
urban areas, and coke-oven emissions. f)
Determine the heritable genetic risk factors
that may modify the disease process and,
hence, identify individuals with an
increased risk of developing adverse health
effects following exposure to environmental
pollutants. g) Undertake studies to help
understand the question of health risks
associated with exposure to morphological-
ly different particles and fibers. h)
Investigate the sensitivity of individuals in
various groups to adverse effects of ozone
and nitrogen dioxide, including people
with asthma, allergies, and chronic respira-
tory diseases, and in other groups that are
suggested by mechanistic studies. i)
Encourage the development and use ofnew
genotoxicity bioassays for in vitro assess-
ment ofthe biological activity ofurban air
samples. End points of particular concern
would be genetic recombination and other
genomic rearrangements that may give rise
to changes in gene expression. j)
Undertake molecular analysis of mutations
induced in Salmonella and in eukaryotic
organisms. k) Undertake limited work to
better understand the potential genotoxic
effects of the semivolatile and the gaseous
phase ofurban air. I) Use molecular stud-
ies to help discern the biological effect of
environmental pollutants involved in can-
cer induction, other than mutations.
Risk Quantification
Risk assessments may be divided into quali-
tative and quantitative approaches (68).
IARC has assessed a number of air pollu-
tants in terms of their carcinogenic proper-
ties (qualitative risk) to humans. In these
assessments, the results ofa large number of
scientific studies are evaluated concerning
the relevance for human cancer. Some indi-
vidual compounds and complex mixtures
formed from combustion products have
been classified as carcinogenic (group 1),
probably carcinogenic (group 2A) or possi-
bly carcinogenic (group 2B) to humans.
Examples are benzene and soot (group 1);
PAHs and diesel engine exhaust (group 2A);
and nitro-PAHs, PAHs, gasoline and heavy
residual oils (group 2B) (Table 3).
It is difficult at this time to use studies of
metabolic mechanisms of carcinogenesis in
risk assessments. From this point ofview, it
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Table 4. Risk estimate for the annual incidence of cancer cases associated with air pollution (cases/year/million
people).
Cancercases/year/million people
Ambient air pollutant United Statesa Sweden b
Particle phase
POM, PAH (as B[aIP) 1.0 11.6
POM (rad-equivalent), all cancers 34.9
Gas phase
1,3-Butadiene 0.9-1.0 5.8
Benzene, leukemia 0.4-0.6 0.6
All cancers 0.4-0.6 1.2
Formaldehyde, all cancers 0.1-0.2 2.9
Acetaldehyde <0.1 <0.1
Ethylene, all cancers 3.5
Gasoline 0.07-0.3
Abbreviations: POM, polycyclic organic material; PAH, polycyclic aromatic hydrocarbons.
8 Data from U.S. EPA(7).
b Data fromTmrnqvist and Ehrenberg(101); based on present average Swedish exposure levels according to Bostrom
etal.(58).
may be noted, however, that IARC, evaluat-
ing each compound from its data, puts
ethene in group 3 (not classifiable), although
it is known to be metabolized to, and give
rise to an in vivodose ofethylene oxide (pre-
sent in group 2A) (90). There is a need to
develop short-term tests that assess genetic
toxicity, cell proliferation, aberrant intercel-
lular communication, receptor mediator
effects (such as are recognized for dioxins),
and changes in gene transcription.
Table 4 presents risk estimates from sev-
eral studies expressed in terms of annual
incidence of cancer in the United States
because of exposure to several air toxics.
These are upper bound estimates because
they are based on the upper 95% confi-
dence interval of the animal responses
extrapolated to humans. In addition, these
calculations assume that everyone in the
representative countries are exposed con-
tinuously to the highest urban air pollution
levels for 24 hr/day. As emphasized at the
meeting, there are large uncertainties asso-
ciated with such risk estimates. A discus-
sion of uncertainties is summarized in this
report and several of the accompanying
papers. The estimated levels oflung cancer
would be higher in areas with high levels of
air pollution such as Shenyang province in
China and several areas in Eastern Europe.
There are a number of problems with
quantitative calculations of cancer risks.
One problem is that these substances can-
not be tested on humans. Other problems
are that it takes 20 to 30 years to develop a
cancer, and after such a long time, there are
a great variety of complications to deter-
mine the dose of the agent. In addition,
there are a number ofconfounding factors
that influence the cancer risk such as life-
style (including smoking, alcohol, and food
habits), age when exposed, duration of
exposure, complex exposures when a num-
ber of different pollutants could be
involved, involvement of drugs and drug
abuse, and virus diseases.
The EPA's 1986 cancer risk guidelines
were based on the fact that the mechanisms
of carcinogenesis were largely unknown.
Research during the past few years to eluci-
date the molecular biology of cancer has
resulted in new findings at an explosive
pace. These scientific studies and the
resulting data base will continue to change
very rapidly. As a result, currently estab-
lished approaches to risk assessment will
have to be very flexible. Such approaches
are being adopted by regulatory agencies in
the United States (91).
Biomarkers
Increasing attention is being paid to the use
ofbiomarkers for determining the integrated
exposure of humans to toxics (68,92,90).
Biomarkers include the nonreacted toxic
substance, their metabolites, or the reaction
products of these toxics with naturally
occurring substances in the body.
Examples ofsuch biomarkers indude DNA
or protein adducts, carboxyhemoglobin,
and DNA oxidation products. Chromo-
somal aberrations and in vivo mutations
also may serve as biomarkers. Macro-
molecular adducts are usually a much more
sensitive end point than cytogenetic
changes (93). Blood can be an ideal medi-
um for the measurement of biomarkers
because it is relatively easy to obtain, and
measurement of serum-blood protein
adducts provides an integrated value for
about 120 days of exposure in humans.
Identification of biomarkers such as car-
cinogen-macromolecule adducts, also may
be useful for identifying sources of expo-
sures (94) as needed for risk identification
(90). In addition, these methods could be
used for validation of exposure and expo-
sure-response models.
Significant progress has been made in
the measurement ofbiomarkers during the
past several years. Much of this progress
has been because of the development of
advanced mass spectrometric techniques
(95). Quantification ofchemically altered
DNA in individuals has been a challenge
because of problems such as low-adduct
levels; efficient repair of the damage, dilu-
tion of adduct levels by cell division, and
other factors. Stimulated by suggestions
from Ehrenberg and his group (84,90,96),
many scientists have focused attention on
protein adducts with the assumption that
levels of carcinogen-protein adducts will
reflect levels of carcinogen-DNA adducts.
For example, the electrophilic intermedi-
ates that react with nucleophilic sites on
DNA also will react with nucleophilic sites
on other molecules such as serum albumin
or hemoglobin (97).
32P-postlabeling methods have been
developed that can be applied to a wide
range ofaromaticDNA adducts (98). The
high sensitivity (one adduct in 10-iO'10
nucleotides), wide applicability of the
assay, and the fact that small amounts of
DNA are required make this assay suitable
for the study of DNA adducts in human
tissue. Such studies are helping to unravel
carcinogen damage to the human genome.
However, it is not always a quantitative
technique for recovering DNA adducts.
More sensitive analytical methods are need-
ed to confirm that the spots detected on
the chromatograms are DNA adducts.
DNA-protein crosslinks induced by
formaldehyde exposure in rats and monkeys
have been identified (99). It was found
that the concentration of DNA-protein
crosslinks for a given exposure concentra-
tion was higher in rats than in monkeys.
An empirical model demonstrated that the
concentrations of DNA-protein crosslinks
in monkeys could be predicted from the
data on rat DNA-protein crosslinks by
adjusting for species differences in volume
and quantity of exposed tissue. This pro-
vides increased confidence in the use of
these data for extrapolation to the human
situation.
Further research is needed to understand
the importance ofspecific DNA or protein
adducts in terms of mutations. Also, the
degree of binding is one important issue
that is of critical importance in dealing
with individual substances. In some short-
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term assays, a quantitative relationship has
been established between levels of specific
DNA adducts and mutagenic frequency.
Biomarkers would be a very good tool in
the field of epidemiology with a defined
protocol. Therefore research is needed to
clarify further the basic understanding of
DNA and protein adducts in relation to
dose as well as health risks. This is espe-
cially the case when exposure is of a com-
plex nature. The levels ofprotein adducts
(which are not repaired) give a more
unequivocal measure of dose than the
direct measurement of DNA adduct levels,
which are subjected to repair at rates that
vary between tissues, cells, and DNA
regions.
MultipathwayExposure
It has become recognized that an accurate
assessment of exposure to air pollutants
should include both inhalation and nonin-
halation pathways of exposure. Exposure
through noninhalation pathways results
when air pollutants are deposited on soil,
crops, and surface waters.
Both primary (direct) and secondary
(indirect) pathways may contribute to the
total uptake of a pollutant. The paths of
exposure are routes by which the person is
exposed through direct inhalation, inges-
tion of dirt and contaminated food prod-
ucts, or dermal absorption. Secondary
pathways of exposure are those that result
from assimilation of the pollutant into a
food source. For example, the dose
received for PAH via food is greater than
the inhaled dose. Some work has been
undertaken to develop a multipathway
health-risk assessment model (100) to esti-
mate the potential acute, chronic, and can-
cer health effects from exposure to air pol-
lutants from stationary sources.
Reative (Comparative)
PotencyMethods
Several major research programs were initi-
ated during the past decade to develop and
validate comparative potency methodolo-
gies for quantifying risk to selected air toxi-
cs. One of these programs, the Integrated
Air Cancer Project was initiated in 1985 by
the EPA (18) to improve the methodolo-
gies and data bases for assessing human
exposure to airborne carcinogens. In
Sweden, a rad-equivalence approach was
developed to estimate the cancer risk from
certain components, particularly the
alkenes in ambient air (101).
In the rad-equivalence approach, the risk
is assumed to be proportional to the target
dose of the carcinogen at a given concen-
Table 5. Estimated cancer incidence in the United States from exposuretovehicle emissions(1990 to 2010)(102).
Cancer cases/year a
Airtoxic 1990 1995 2000 2010
1,3-Butadiene 70-560 48-385 41-324 47-386
Diesel particles 109 66 39 27
Benzene 41-118 25-72 21-59 18-53
Formaldehyde 44-133 28-85 21-63 22-67
Acetaldehyde 53-13.4 3.6-9.1 2.8-7.1 3.0-7.6
Total 269.3-933.4 170.6-617.1 124.8-492.1 117-540.6
a 95% upper confidence estimates.
tration; the rate of formation of the DNA
adducts is proportional to the rate of for-
mation of hemoglobin adducts. This is
only valid for certain groups of chemicals
because the biologically active metabolites
may react differently with hemoglobin and
DNA as their nucleophilicity in DNA dif-
fer.
In relevant biological systems the geno-
toxic effectiveness of a compound is com-
pared to the genotoxic effectiveness of
gamma-rays or X-rays. In general, the risk
estimates have been made on the basis of
animal data, but in the absence ofsuch data,
an intermediate biological end point like
hemoglobin adducts was used (90). The
association ofriskwith a chemical end point
increases the sensitivity by several orders of
magnitude.
Nevertheless, the rad-equivalence approach
has proven to be a useful model in which sev-
eral ofthe assumptions have been tested and
validated for particular compounds such as
ethylene oxide in animal experiments.
Moreover, the principles of the rad-equiva-
lence approach should be possible to adopt to
anyDNA-reactive chemicals.
Table 4 gives the risk estimate for the
annual incidence of cancer cases in the
United States and Sweden as based upon
the unit risk factors and rad-equivalence
approaches, respectively. In Table 4, aver-
age cancer risks in Sweden have been sum-
marized for a few air pollution components
at the person-weighted average concentra-
tions determined by Bostrom et al. (58).
These risk estimates were based on the rad-
equivalence (for alkenes and, via animal
experiments, for benzo[a]pyrene), on epi-
demiological data, and on results of long-
term animal studies (101). Because only a
few components were considered, and with
regard to the uncertainty of the estimates
(by a factor of three), the authors did not
try to estimate the total risk.
The risks estimated by Tornqvist and
Ehrenberg (101) are some 10 times higher
than those obtained by applying the Unit
Risk Factor (URF). Some ofthe causes for
the differences between the unit risk factors
and the rad-equivalence approach is the
hypothetical expectation that the risk is a
function of the lifetime accumulated dose
rather than of the dose per day, and that
the genotoxins will cause cancer in most
organs as with ionizing radiation. A reli-
able risk estimate can't be made without
proper integration of data sets for exposed
humans and experimental systems at rele-
vant low exposure levels.
UnitRiskFactors
The URFs are derived from the analyses
presented in the previous section. URFs
are estimates of the probability that an
individual will develop cancer when
exposed to a pollutant at an ambient con-
centration of 1 pg/m3 (7). Unit risk assess-
ments have been used as the primary
approach of regulatory agencies in the
United States to assess and control human
exposure to toxic airpollutants.
The most comprehensive use of this
approach has been a recent assessment of
the potential cancer risk associated with
exposure to vehicle emissions in the United
States (102). The primary toxic emissions
considered in this assessment included ben-
zene, formaldehyde, 1,3-butadiene,
acetaldehyde, diesel particles, and gasoline
particles. The mass emissions ofthese toxi-
cs were determined as a function ofvehicle
technology and fuel composition. These
emission factors were used in a model to
calculate annual average exposures. The
annual average exposures were then multi-
plied by the population ofinterest and the
unit risk factor to estimate the cancer inci-
dence in the United States from exposure
to vehicle emissions (Table 5) (102).
Table 5 summarizes the estimated cancer
incidence in the United States from expo-
sure to vehicle emissions for scenarios in
the 1990 to 2010 timeperiods. Forall years,
1,3-butadiene is responsible for the majori-
ty ofthe cancer incidence. The California
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Air Resources Board (CARB) estimated
that these five toxics can account for more
than 99% of the cumulative cancer cases
attributable to motor vehicles (103).
It is recognized that there are some limi-
tations inherent in these methods of risk
assessment. Caution must be used in
deriving numerical risk factors from animal
data for predicting the incidence of health
effects in humans. The identification of a
health effect, such as cancer in animals,
provides a warning that the agent tested
has the potential for causing a similar effect
in humans. The degree ofconfidence with
which the URF can be developed from the
animal data is proportional to the degree of
confidence one has that the exposure con-
ditions (exposure route, tissue dose, etc.),
and the biological response observed in the
animal study would be relevant for human
exposure conditions. Phenomena occur-
ring in humans and not usually considered
in animal studies, such as transplacental
and neonatal exposure, should be taken
into account.
Understandingly, the mechanisms by
which the health effect is produced is a key
to these extrapolations. Research is pro-
gressively revealing the individual events or
steps leading to the expression of disease.
However, the complete mechanisms or
sequence of steps are not yet known for
most ofthese events at the high doses used
in the animal tests. In addition, multiple
genetic and epigenetic changes are likely to
be involved. As the knowledge of the
events is acquired, it should be applied to
the interpretation of bioassay results. The
value of numerical risk estimates derived
from bioassays is increased in proportion to
the certainty that the same pathogenetic
steps occur in bioassays and humans.
Unit risk estimates result from interac-
tive analyses ofhealth-affecting processes in
the human body and observed effects in
human populations (epidemiology). The
use of unit risk estimates implies knowl-
edge that the dose-risk relationship is lin-
ear. Unit risk estimates can only be made
from experimental data if there is reason-
able certainty that effects in humans could
occur by the same mechanisms as those in
animals.
Observations of the dose-effect relation-
ship at low-exposure levels could provide
data to test the assumption of linearity.
Although such relationships have been
established over several orders of magni-
tude in bacterial assays, such experiments
have only rarely been conducted in ani-
mals.
Table 6. The relationships between risk ratios, cancer incidence, and excess cancercases.
Cancer incidence, cases/year/i 06 people
Total cases Excess cases
Risk ratio Lung cancer All cancers Lung cancer All cancers
1.0000 567a 3,766a 0 0
1.0022 568 3,774 1 8
1.1000 624 4,143 57 377
1.2000 680 4,519 113 753
1.5000 851 5,649 284 1,883
aUnited States cancer incidence in 1989 (2). bEstimated excess cancer cases caused by annual exposure to toxic
ambient air pollutants in the United States, 2,200 cases total (7).
Although these methods are not very
reliable for estimating absolute risk, they
can be used in a relative sense to compare
risks among pollutants and scenarios and to
assess trends.
HumanExposure/Rodent
PotencyIndex
Several approaches tothedevelopmentofrelative
risk scales have been proposed recentlyfor com-
paring possible hazards from several different
exposures. Gold et al. (104) has recommended
the use ofa human exposure/rodent potency
index (HERP). It is an index ofpossible haz-
ard rather than adirectestimateofriskbecause
bioassay results do notprovide sufficient infor-
mation to estimate human risk at low dose.
HERP indicates the percentage ofthe rodent
potency (TD50, in milligrams per kilogram
per day). TD50 is the human exposure per
kilogram body weight estimated to halve the
proportion oftumor-free animals by the end
ofa standard lifetime. Values ofTD50 span a
10-million fold range. This may become a
useful approach to help regulators andthegen-
eralpublic become more awareoftheconcepts
ofrelative risks.
Epidemiology
Good epidemiologic data is avaluable tool in
identifying and, in some cases, quantifying a
risk. Because epidemiologic studies refer
directly to humans, they have two powerfil
advantages: They entail no interspecies
extrapolation, and they do not require
extrapolation from the high doses commonly
used with experimental animals to the low
doses to which people in the general popula-
tion are likely to be exposed. However, the
epidemiologic approach has a number of
limitations. The risks for large populations
are below the detection limits ofpresent epi-
demiological methodology (105). Table 6
gives the relationships between risk ratios
(RR), cancer incidence, and excess cancer
cases (per year for a million people). Risk
ratios below about 1.15 are not possible to
determine accurately (within 90 to 95% con-
fidence intervals) using current epidemiologic
approaches because of several limitations.
Such limitations include the difficulty in
finding study groups in which two distinct
populations can be identified that are similar
in nearlyall regards but differingwith respect
to the factor (exposure) to be studied, the
limited population of the exposed group,
known and unknown confounding factors
(e.g. exposure to secondary cigarette smoke),
and imprecise estimation of exposures. As
discussed earlier, the EPA estimated that
there are approximately 2200 excess cancer
cases caused by annual exposure to toxic
ambient-air pollutants in the United States.
These excess cases translate to a risk ratio of
1.0022 (Table 6). Thus, it is not possible to
use an epidemiological approach to deter-
mine directly the excess cancer cases that
have been estimated to be caused by annual
exposure to toxic ambient-air pollutants in
thegeneral population.
Hemminki and Pershagen (105) analyzed
data from several reported epidemiologystud-
ies and conduded that the relative lung-can-
cer risk ratio (RR) for people living in urban
areas compared to people living in the coun-
tryside can be as high as 1.5. Frequently,
these risk ratios have been explained bydiffer-
ences in exposure to air pollutants; however,
such correlations might have other explana-
tions and cannot represent final conclusive
evidence. Therefore, analytic epidemiological
studies (cohort or case-control studies) are
required to clarify whether there is an
increased risk ofdeveloping lung cancers for
individuals with an increased exposure to air
pollutants (106).
Additional epidemiological studies are
needed on cancer risks between popula-
tions living in highly polluted urban areas
(e.g., Silesia, Poland) (17) compared to
similar groups of people living-in adjacent
rural areas. Inaccurate exposure data and
uncontrolled confounding factors consti-
tute major problems in the interpretation
of the epidemiological evidence on health
risks related to ambient air pollution.
Environmental Health Perspectives 206FUTURERESEARCHNEEDS
Further studies should focus on obtaining
more accurate exposure data and better
control ofconfounding factors.
Studies on the exposure ofselected occu-
pational groups have shown a causative
effect between exposure to toxic air pollu-
tants and lung cancer. Perhaps the most
robust of the cohort studies (82) were
those of Boffeta et al. (107) and Garshick
et al. (108). Boffetta et al. reported a RR
for lung cancer among diesel exhaust
exposed subjects of 1.6 for railroad work-
ers, 2.6 for heavy equipment operators, and
2.7 for miners who worked in mines where
diesel equipment was operated. Garshick
et al. conducted a retrospective study of
U.S. railroad workers by inferring exposure
from job title, assuming that workers with
the greatest diesel emissions exposure were
the youngest at the time railroads were
converted to diesel engines, and judging
that smoking prevalence was the same
among workers in relatively exposed and
unexposed jobs. They calculated a RR for
lung cancer of 1.5 for the group that was
youngest at the time of diesel conversion
and lower RR values for groups older at
that time.
A number ofrisk assessment studies have
been initiated for selected populations liv-
ing in developing countries. One such
group is that of Chinese women who have
high levels of exposure to air pollutants
emitted from unvented coal-fueled stoves.
A significant increased risk of lung cancer
(RR of 2.5) was observed for this group
(106). Current studies on this group are
needed including exposure and biomarker
measurements and the incidence of other
adverse health effects.
Several epidemiological studies have
indicated that interactions ofcomplex mix-
tures do occur (109). In general, it appears
that the mechanism varies from purely
additive through purely multiplicative.
Because of the small size of the sample
population groups it has not been possible
to obtain a good quantitative model of
interactions. However, it appears that
when a mixture contains key carcinogens
that fall within the same chemical class,
then the carcinogenicity could be equiva-
lent to the sum ofthe effects ofthe individ-
ual classes.
The epidemiological connection between
smoking and certain types of lung cancer
has been well established (110). Smoking
is estimated to account for about 294,000
cancer cases per year in the United States.
However, even though about 50 carcino-
genic chemicals have been identified in ciga-
rette smoke, it has been difficult to establish
a quantitative link between the exposure of
these individual compounds and cancer.
Workers in foundries are exposed to
high levels ofair pollutants. A lung-cancer
risk estimate of 1.5 to 1.7 has been deter-
mined from a number of studies (111).
However, because these workers are
exposed to many different sources ofemis-
sions, it is probably not possible to identify
the specific components responsible for this
increased risk.
Current human exposure to air pollu-
tants, especially in certain urban areas with
high air pollution levels, can give rise to an
increased cancer risk in the coming
decades. Therefore, ifhuman and environ-
mental samples could be collected and
archived, such samples would be of great
value for future epidemiologic studies.
Reommendations
Interdisciplinary collaboration involving
both epidemiology, experimental, and
human clinical toxicology, and including
accurate and meaningful exposure assess-
ments is required to understand human
health risks from airborne agents. This col-
laboration should occur on an international
basis, and its efforts should focus on the
following: a) Develop a comprehensive
computer-based risk assessment model that
can readily incorporate new scientific find-
ings as they are discovered. b) Expand
efforts to understand the best approach for
identifying hazards and estimating risk for
combined exposures as these are more rep-
resentative for the actual exposure. c)
Consider tumor locations other than the
lung in epidemiologic studies. d) Develop
short-term tests that assess genetic toxicity,
cell proliferation, aberrant intercellular
communication, receptor mediator effects
(such as are recognized for dioxins), and
changes in gene transcription. e) Effect of
reducing the existing uncertainties in the
risk assessment methods. f) Identify spe-
cific biomarkers ofenvironmental exposure
that give an accurate assessment of dose.
g) Develop rapid, inexpensive, and more
sensitive analytical methods for the analysis
of biomarkers in blood or urine. h)
Develop DNA-adduct analyses techniques
to detect and quantify the target dose of
specific exposures. i) Elucidate the nature
of the association of DNA adducts with
exposure and mutations in order for this
assay to be used as a specific marker. j)
Obtain a better understanding for DNA
adduct formation kinetics and repair mech-
anisms as necessary for the identification of
adduct hot spots. k) Clarify the kinetics of
DNA repair in terms ofpermitting the cal-
culation of dose from steady-state DNA
adduct levels. I) Focus epidemiological
studies on highly polluted areas such as
Cairo, Mexico City, Beijing, and heavily
industrialized areas in Eastern Europe. m)
Determine the degree of binding; individ-
ual adducts versus the total amount of
adducts in terms of dose and risk, respec-
tively; and the analytical problems with
adduct analyses after complex exposures.
Conclusions
Regulatory agencies rely heavily on quantita-
tive assessments ofenvironmental health risks
as the scientific basis for decisions about how
best to protect public health. Significant sci-
entific advances have been made during the
past decade to improve the accuracy of the
risk assessment process. Such advances have
been made in the identification ofpotentially
toxic compounds in emission sources and
ambient air, atmospheric transport and chem-
istry, and exposure quantification. By pro-
viding the methods to make biological mea-
surements of changes in genes, cells, and
physiologic processes, the revolution in mole-
cular biology has paved the way to measure
environmental exposures moreaccurately and
precisely, to define better associated health
effects, and to improve the determination of
susceptibilitytopollutantexposures.
Although great progress has been made,
the workshop participants concluded that
there are still significant deficiencies in the
data bases used in risk assessments as well as
the risk assessment approach itself. Aside
from the previously noted problems ofinad-
equate emission inventories, the difficulty of
accurately assessing and quantifying expo-
sure, and determining the resulting health
end point from that exposure, several other
areas have been identified where technical
improvements are needed.
There are numerous steps associated with
the development of quantitative unit risk
factors as summarized in the various sec-
tions ofthis paper and illustrated by Figure
4. Because our knowledge base for each of
these steps is incomplete, there is a high
level ofuncertainty associated with develop-
ing an absolute quantitative value for a
health risk. Additional efforts will be need-
ed to reduce the uncertainties in each step
ofthe risk assessment process as an impor-
tant part of carrying out the research rec-
ommendations presented in this report.
In the future, any quantitative expressions
of risk that are reported in the scientific
and popular literature should include an
assessment ofuncertainty levels.
The most effective approach to improving
the technical basis for risk assessment is
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through expanded international collaborative
research and development efforts. In this
regard, increased collaborative efforts are
needed between industry and government
organizations. Such efforts should include
the development of low-cost and effective
emissions control strategies. Other areas of
potential cooperation include technology
transfer, development ofreference materials
for chemical and biological assays, and qual-
ity assurance techniques to ensure that labo-
ratories around the world produce compa-
rable results. Epidemiological studies from
different parts ofthe world should be com-
bined iffeasible to clearly establish the role
of urban air pollution on the health and
well-being ofpeople.
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